Portfolio news 0

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Half Year Trading Update

Enterprise Therapeutics

Enterprise Therapeutics Doses First Person with Cystic Fibrosis in Phase 2 Trial for Novel Therapy ETD001

Oxford Nanopore Technologies Plc

Oxford Nanopore and Plasmidsaurus announce collaboration and multi-year, multi-million dollar contract expansion

Hinge Health, Inc.

Hinge Health - Sun Life taps Hinge Health as preferred digital musculoskeletal solution for members

Mixergy Ltd

Daikin partner with Mixergy to offer unparalleled benefits for social housing retrofit and new build

Abliva

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

Intelligent Ultrasound Group plc

Intelligent Ultrasound Group plc - Proposed sale of the Clinical AI Business to GE HealthCare for £40.5m

Genomics

Genomics Announces New Extension and Expansion of Drug Discovery Collaboration with Vertex

Tissue Regenix Group plc

Tissue Regenix Group plc - Half-Year Trading Update and Notice of Results

MoA Technology Ltd

Moa harvests global deal for new herbicide